Surmodics is a medical device maker that makes coatings for medical devices and manufactures chemicals for diagnostic immunoassay tests The company will make a drug-coated balloon that will be sold by ...

Surmodics looks to pave a new path forward after the FDA sent a device submission back for revision yet again. The device in question is its SurVeil drug-coated balloon, which is threaded into a blood ...

Surmodics (NASDAQ:SRDX) is set to give its latest quarterly earnings report on Wednesday, 2025-04-30. Here's what investors need to know before the announcement. Analysts estimate that Surmodics will ...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care ...

It’s taken two years, but Surmodics has finally secured the long-awaited premarket approval from the FDA for its SurVeil drug-coated balloon. Surmodics announced the good news in a Tuesday press ...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ: SRDX), the global leader in medical device coating technologies, announced the commercial launch of its most advanced hydrophilic medical ...

GTCR announced its acquisition of Surmodics for $627 million GTCR invested in Biocoat, a specialty manufacturer of hydrophilic biomaterial coatings, services and dip-coating equipment for medical ...

Surmodics, Inc. (NASDAQ:SRDX) shares are trading lower in the premarket session on Friday. The firm’s stock dipped following news that the U.S. Federal Trade Commission will challenge the proposed ...

Promising new clinical results to treat cardiovascular disease by coating implanted devices with drugs helped pump up trading activity for a Twin Cities company on Tuesday. Shares for Surmodics Inc.

Surmodics SRDX is gaining traction on prudent acquisitions along with portfolio expansion. Recent regulatory clearances and progress with TRANSCEND enrollment have also been key growth drivers. The ...